blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1682107

EP1682107 - ANTI-TUMOUR TERPENE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.06.2010
Database last updated on 02.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Compton Developments, Ltd.
P.O. box 425
Swansea SA6 8YH / GB
[2006/30]
Inventor(s)01 / BOWEN, Ifor, Delme, Cardiff University
BioMedical Sciences Bldg., Museum Av., P.O.Box 911
Cardiff CF10 3US / GB
02 / ALI, Ahmed, Yasine, Cardiff University
BioMedical Sciences Bldg., Museum Av., P.O.Box 911
Cardiff CF10 3US / GB
 [2006/30]
Representative(s)Tombling, Adrian George, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2006/30]Tombling, Adrian George, et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW / GB
Application number, filing date04798492.712.11.2004
[2006/30]
WO2004GB04769
Priority number, dateGB2003002651813.11.2003         Original published format: GB 0326518
[2006/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005049001
Date:02.06.2005
Language:EN
[2005/22]
Type: A1 Application with search report 
No.:EP1682107
Date:26.07.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application.
[2006/30]
Type: B1 Patent specification 
No.:EP1682107
Date:12.08.2009
Language:EN
[2009/33]
Search report(s)International search report - published on:EP02.06.2005
ClassificationIPC:A61K31/01, A61K31/015, A61P35/00
[2006/30]
CPC:
A61K31/015 (EP,US); A61K31/01 (EP,KR,US); A61K36/328 (EP,US);
A61P35/00 (EP); A61P35/02 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/30]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ANTITUMORALE TERPEN-VERBINDUNGEN[2006/30]
English:ANTI-TUMOUR TERPENE COMPOUNDS[2006/30]
French:COMPOSES TERPENIQUES ANTITUMORAUX[2006/30]
Entry into regional phase12.05.2006National basic fee paid 
12.05.2006Designation fee(s) paid 
12.05.2006Examination fee paid 
Examination procedure12.05.2006Examination requested  [2006/30]
26.10.2006Despatch of a communication from the examining division (Time limit: M06)
16.04.2007Reply to a communication from the examining division
10.11.2008Cancellation of oral proceeding that was planned for 12.11.2008
10.11.2008Minutes of oral proceedings despatched
12.11.2008Date of oral proceedings
12.11.2008Date of oral proceedings (cancelled)
14.11.2008Despatch of a communication from the examining division (Time limit: M02)
28.11.2008Reply to a communication from the examining division
13.02.2009Communication of intention to grant the patent
16.06.2009Fee for grant paid
16.06.2009Fee for publishing/printing paid
Opposition(s)17.05.2010No opposition filed within time limit [2010/29]
Fees paidRenewal fee
10.11.2006Renewal fee patent year 03
21.11.2007Renewal fee patent year 04
13.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.08.2009
BE12.08.2009
CY12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
IT12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
TR12.08.2009
BG12.11.2009
LU12.11.2009
GR13.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
HU13.02.2010
[2011/44]
Former [2011/32]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
IT12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
LU12.11.2009
GR13.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
HU13.02.2010
Former [2011/21]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
IT12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
LU12.11.2009
GR13.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
Former [2011/15]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
IT12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
GR13.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/51]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
GR13.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/30]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
ES23.11.2009
MC30.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/28]AT12.08.2009
BE12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
ES23.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/23]AT12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
SK12.08.2009
BG12.11.2009
ES23.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/22]AT12.08.2009
CZ12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
RO12.08.2009
SI12.08.2009
BG12.11.2009
ES23.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/20]AT12.08.2009
EE12.08.2009
FI12.08.2009
PL12.08.2009
SI12.08.2009
BG12.11.2009
ES23.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/17]AT12.08.2009
FI12.08.2009
PL12.08.2009
SI12.08.2009
BG12.11.2009
ES23.11.2009
IS12.12.2009
PT12.12.2009
Former [2010/11]AT12.08.2009
FI12.08.2009
PL12.08.2009
SI12.08.2009
ES23.11.2009
IS12.12.2009
Former [2010/10]AT12.08.2009
FI12.08.2009
PL12.08.2009
ES23.11.2009
IS12.12.2009
Cited inInternational search[DA]WO9420080  (US HEALTH [US]) [DA] 1-10* the whole document *;
 [DX]WO0180868  (ROUGEREAU PERSON ODILE [FR], et al) [DX] 1,2,5-8 * abstract *;
 [X]WO0207744  (GIRAUD ANNE MARIE PIERRETTE [FR]) [X] 1-8 * page 13, line 26 - page 21, line 14; example - *;
 [X]WO02053138  (SHANAHAN-PRENDERGAST ELISABETH [IE]) [X] 1,2,4-8 * abstract *;
 [Y]WO02080951  (SYNERGISTIX BIOTECH INC [US], et al) [Y] 9,10 * abstract *;
 [PX]WO2004066912  (TECHNION RES & DEV FOUNDATION [IL], et al) [PX] 1,2,4-8 * abstract * * page 1, line 9 - line 11 * * page 2, line 1 - line 5 * * page 26, line 29 - line 30 * * page 27, line 20 - line 22; claims 77,97-103,127,143 *;
 [DX]  - TATMAN D ET AL, "VOLATILE ISOPRENOID CONSTITUENTS OF FRUITS, VEGETABLES AND HERBS CUMULATIVELY SUPPRESS THE PROLIFERATION OF MURINE B16 MELANOMA AND HUMAN HL-60 LEUKEMIA CELLS", CANCER LETTERS, NEW YORK, NY, US, (2002), vol. 175, no. 2, ISSN 0304-3835, pages 129 - 139, XP008037328 [DX] 1-3,5-8 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0304-3835(01)00723-6
 [DXY]  - QURESHI S ET AL, "EVALUATION OF THE GENOTOXIC, CYTOTOXIC, AND ANTITUMOR PROPERTIES OFCOMMIPHORA MOLMOL USING NORMAL AND EHRLICH ASCITES CARCINOMA CELL-BEARING SWISS ALBINO MICE", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, (1993), vol. 33, no. 2, ISSN 0344-5704, pages 130 - 138, XP001035052 [DX] 1-8 * the whole document * [Y] 9,10

DOI:   http://dx.doi.org/10.1007/BF00685330
 [DXY]  - AL-HARBI M M ET AL, "ANTICARCINOGENIC EFFECT OF COMMIPHORA MOLMOL ON SOLID TUMORS INDUCED BY EHRLICH CARCINOMA CELLS IN MICE", CHEMOTHERAPY, S. KARGER, BASEL, CH, (199409), vol. 40, no. 5, ISSN 0009-3157, pages 337 - 347, XP001035099 [DX] 1-8 * the whole document * [Y] 9,10
 [X]  - SALEH M M ET AL, "Cytotoxicity and in vitro effects on human cancer cell lines of volatiles of Apium graveolens var. filicum", PHARMACEUTICAL AND PHARMACOLOGICAL LETTERS, (199804), vol. 8, no. 2, ISSN 0939-9488, pages 97 - 99, XP008041812 [X] 1,2,5-8 * the whole document *
 [DX]  - LEAL PATRICIA F ET AL, "Functional properties of spice extracts obtained via supercritical fluid extraction.", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, (20030423), vol. 51, no. 9, ISSN 0021-8561, pages 2520 - 2525, XP008041804 [DX] 1,2,5-8 * the whole document *

DOI:   http://dx.doi.org/10.1021/jf0260693
Examination   - "Gummi Myrrha", WHO MONOGRAPHS ON SELECTED PLANTS, pages 247 - 256
    - BASER K.H.C. ET AL, FLAVOUR AND FRAGRANCE JOURNAL, (2003), vol. 18, pages 153 - 156
    - DEKEBO A. ET AL, FITOTERAPIA, (2002), vol. 73, pages 48 - 55
    - HANUS L.O., BIOMED. PAPERS, (2005), vol. 149, no. 1, pages 3 - 28
    - THULIN M. ET AL, ECONOMIC BOTANY, (1991), vol. 45, no. 4, pages 487 - 494
by applicantUS5602184
 WO0050053
 WO0180868
 US2002155522
 US6486706
    - QURESHI; AL HARBI ET AL., CANCER CHEMOTHERAPY AND PHARMACOLOGY, (1993), vol. 33, pages 130 - 138
    - RAO ET AL., J. ETHNOPHARMACOLOGY, (2001), vol. 76, pages 151 - 154
    - TATMAN ET AL., CANCER LETTERS, (2002), vol. 175, pages 129 - 139
    - LEAL ET AL., J. AGRIC. FOOD. CHEM., (2003), vol. 51, pages 2520 - 2525
    - SALEH ET AL., PHARM. PHARMACOL. LETT., (1998), vol. 8, pages 97 - 99
    - ITOKAWA ET AL., CHEM. PHARM. BULL., (1985), vol. 33, pages 3488 - 3492
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.